West Asia shipping disruptions
Container shipment constraints to West Asia and Asia impacted international business; Q1 remains uncertain.
high · management_commentaryJ B Chemicals and Pharmaceuticals Ltd — Q4 FY26
JB Chemicals reported a weak Q4 FY26 with revenue of ₹904 crore, down 5% YoY, as the quarter was an operational reset post Torrent Pharma's acquisition.
neutral
medium
✓ Verified against BSE filing
Risk Intelligence
Material risks this quarter
Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.
Risks
CDMO execution delays
CDMO business faces delays in product development and delivery of new contracts, which could hinder growth.
medium · analyst_questionTrade generics rationalization drag on India growth
Discontinuation of trade generics (7-8% of India sales) will continue to suppress reported India growth for next 3 quarters.
medium · analyst_questionField force attrition and integration challenges
Higher attrition in JB's field force and potential rationalization may disrupt sales momentum.
medium · analyst_question